Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FONAR Co. stock logo
FONR
FONAR
$16.86
+4.1%
$20.81
$12.13
$24.05
$106.72M1.1218,875 shs17,010 shs
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$0.83
+2.5%
$1.05
$0.80
$3.28
$59.79M0.7569,899 shs21,995 shs
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
$2.32
-2.5%
$0.00
$1.33
$3.29
$190.54M1.34307,300 shs481,921 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FONAR Co. stock logo
FONR
FONAR
+1.12%-2.00%-25.90%-17.69%+4.25%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-1.10%-10.99%-25.00%-18.18%-42.96%
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
0.00%0.00%+2.79%+47.43%-50.48%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/AN/AN/AN/A
Hyperfine, Inc. stock logo
HYPR
Hyperfine
1.3001 of 5 stars
3.22.00.00.00.01.71.3
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
2.2334 of 5 stars
3.53.00.00.01.91.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/A
Hyperfine, Inc. stock logo
HYPR
Hyperfine
2.33
Hold$2.12154.71% Upside
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
3.00
Buy$4.5093.97% Upside

Current Analyst Ratings

Latest STXS, FONR, and HYPR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Hyperfine, Inc. stock logo
HYPR
Hyperfine
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$2.10 ➝ $1.60
3/5/2024
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$3.00 ➝ $4.00
3/5/2024
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FONAR Co. stock logo
FONR
FONAR
$98.64M1.08$2.93 per share5.76$23.07 per share0.73
Hyperfine, Inc. stock logo
HYPR
Hyperfine
$11.03M5.42N/AN/A$1.17 per share0.71
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
$26.77M7.12N/AN/A$0.20 per share11.60

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FONAR Co. stock logo
FONR
FONAR
$9.38M$1.849.16N/A12.63%8.47%6.45%5/20/2024 (Estimated)
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$44.24M-$0.62N/AN/AN/A-401.00%-44.89%-40.96%5/9/2024 (Estimated)
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
-$20.71M-$0.28N/AN/AN/A-77.37%-103.37%-44.67%N/A

Latest STXS, FONR, and HYPR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
Hyperfine, Inc. stock logo
HYPR
Hyperfine
-$0.17-$0.15+$0.02-$0.15$3.66 million$2.69 million
3/4/202412/31/2023
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
-$0.07-$0.07N/A-$0.07$7.55 million$4.57 million    
2/14/2024Q2 2024
FONAR Co. stock logo
FONR
FONAR
N/A$0.54+$0.54$0.54N/A$25.39 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/A
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/AN/AN/AN/AN/A
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FONAR Co. stock logo
FONR
FONAR
N/A
9.35
9.15
Hyperfine, Inc. stock logo
HYPR
Hyperfine
N/A
10.14
9.39
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
N/A
2.51
1.88

Ownership

Institutional Ownership

CompanyInstitutional Ownership
FONAR Co. stock logo
FONR
FONAR
50.64%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
15.03%
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
45.35%

Insider Ownership

CompanyInsider Ownership
FONAR Co. stock logo
FONR
FONAR
2.17%
Hyperfine, Inc. stock logo
HYPR
Hyperfine
26.50%
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
18.52%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
FONAR Co. stock logo
FONR
FONAR
5616.33 million6.19 millionNot Optionable
Hyperfine, Inc. stock logo
HYPR
Hyperfine
13171.95 million52.88 millionOptionable
Stereotaxis, Inc. stock logo
STXS
Stereotaxis
12282.13 million66.92 millionNot Optionable

STXS, FONR, and HYPR Headlines

SourceHeadline
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
globenewswire.com - April 22 at 7:51 AM
3 Penny Stocks That Could Make a Big Comeback by the End of Q23 Penny Stocks That Could Make a Big Comeback by the End of Q2
investorplace.com - April 19 at 6:00 AM
Stereotaxis Inc.Stereotaxis Inc.
barrons.com - April 17 at 11:22 PM
7 Penny Stocks That Could 5X by the End of 20247 Penny Stocks That Could 5X by the End of 2024
investorplace.com - April 10 at 9:22 AM
Stereotaxis (NYSEAMERICAN:STXS) Trading 4.4% Higher Stereotaxis (NYSEAMERICAN:STXS) Trading 4.4% Higher
marketbeat.com - March 29 at 12:57 AM
Stereotaxis Set for Breakout Growth: Buy Rating Affirmed Amidst Regulatory Advances and Robust FinancialsStereotaxis Set for Breakout Growth: Buy Rating Affirmed Amidst Regulatory Advances and Robust Financials
markets.businessinsider.com - March 19 at 12:29 AM
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck WithLow-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
investorplace.com - March 17 at 2:58 PM
Major Regulatory Approvals Coming For Stereotaxis In The Next 10 MonthsMajor Regulatory Approvals Coming For Stereotaxis In The Next 10 Months
seekingalpha.com - March 9 at 8:21 AM
Stereotaxis (STXS) Seeks Clearance for MAGiC CatheterStereotaxis (STXS) Seeks Clearance for MAGiC Catheter
zacks.com - March 8 at 8:50 AM
Stereotaxis, Inc. (STXS) Q4 2023 Earnings Call TranscriptStereotaxis, Inc. (STXS) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 6 at 4:12 PM
St. Louis public company projects breakout growth as revenue falls, loss widensSt. Louis public company projects 'breakout growth' as revenue falls, loss widens
bizjournals.com - March 6 at 4:12 PM
Stereotaxis submits Magic ablation catheter for U.S., European approvalStereotaxis submits Magic ablation catheter for U.S., European approval
massdevice.com - March 5 at 10:51 AM
Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call TranscriptStereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 5 at 10:51 AM
Recap: Stereotaxis Q4 EarningsRecap: Stereotaxis Q4 Earnings
benzinga.com - March 4 at 6:33 PM
Analysts Are Bullish on These Healthcare Stocks: Stereotaxis (STXS), LifeMD (LFMD)Analysts Are Bullish on These Healthcare Stocks: Stereotaxis (STXS), LifeMD (LFMD)
markets.businessinsider.com - March 4 at 6:33 PM
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United StatesStereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
globenewswire.com - March 4 at 4:06 PM
Stereotaxis Reports 2023 Full Year Financial ResultsStereotaxis Reports 2023 Full Year Financial Results
globenewswire.com - March 4 at 4:05 PM
Stereotaxis Q4 2023 Earnings PreviewStereotaxis Q4 2023 Earnings Preview
msn.com - March 3 at 7:36 PM
Earnings Preview For StereotaxisEarnings Preview For Stereotaxis
benzinga.com - March 1 at 12:39 PM
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
markets.businessinsider.com - February 23 at 2:06 PM
Stereotaxis, Inc.: Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic TechnologyStereotaxis, Inc.: Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology
finanznachrichten.de - February 23 at 9:05 AM
Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic TechnologyIntermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology
finance.yahoo.com - February 22 at 6:47 PM
Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic TechnologyIntermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology
globenewswire.com - February 22 at 4:15 PM
Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
finance.yahoo.com - February 20 at 9:18 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

FONAR logo

FONAR

NASDAQ:FONR
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.
Hyperfine logo

Hyperfine

NASDAQ:HYPR
Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.
Stereotaxis logo

Stereotaxis

NYSEAMERICAN:STXS
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.